Robert J Kinders Selected Research

Mucositis

2/2017

A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert J Kinders Research Topics

Disease

49	Neoplasms (Cancer) 12/2023 - 11/2008
5	Breast Neoplasms (Breast Cancer) 12/2023 - 01/2020
5	Circulating Neoplastic Cells 01/2020 - 02/2010
4	Triple Negative Breast Neoplasms 12/2022 - 03/2012
4	Carcinoma (Carcinomatosis) 01/2020 - 01/2015
4	Ovarian Neoplasms (Ovarian Cancer) 02/2016 - 03/2012
4	Hypoxia (Hypoxemia) 08/2014 - 07/2009
3	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2018
3	Lymphoma (Lymphomas) 11/2020 - 03/2012
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 06/2015
2	Peritoneal Neoplasms 01/2017 - 01/2015
2	Fallopian Tube Neoplasms 01/2017 - 04/2015
2	Carcinogenesis 08/2015 - 01/2011
1	Endometrial Neoplasms (Endometrial Cancer) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Mucositis 02/2017
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 02/2017
1	Leukemia 02/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2017
1	Fanconi Anemia (Fanconi's Anemia) 02/2017
1	Fatigue 01/2017
1	Ovarian Epithelial Carcinoma 02/2016

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 12/2023 - 07/2009
11	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 09/2010
10	veliparibIBA 02/2017 - 11/2008
9	Proteins (Proteins, Gene)FDA Link 11/2020 - 02/2014
7	Topotecan (Hycamtin)FDA LinkGeneric 03/2018 - 07/2009
6	EnzymesIBA 12/2023 - 07/2009
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2010
5	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2016 - 11/2008
4	Histones (Histone)IBA 02/2017 - 10/2015
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 03/2012
3	birinapantIBA 03/2018 - 02/2016
3	Phosphotransferases (Kinase)IBA 01/2018 - 04/2013
3	Poly Adenosine Diphosphate RiboseIBA 01/2016 - 01/2011
2	Epithelial Cell Adhesion MoleculeIBA 12/2023 - 01/2016
2	Interferon-gamma (Interferon, gamma)IBA 11/2023 - 04/2023
2	CytokinesIBA 11/2023 - 04/2023
2	Messenger RNA (mRNA)IBA 01/2021 - 02/2014
2	adavosertibIBA 01/2021 - 10/2015
2	Temozolomide (Temodar)FDA LinkGeneric 11/2020 - 02/2017
2	NSC 724998IBA 12/2018 - 07/2016
2	Topoisomerase I InhibitorsIBA 12/2018 - 03/2018
2	AntibodiesIBA 01/2018 - 01/2016
2	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2016
2	PlatinumIBA 01/2018 - 02/2016
2	Bevacizumab (Avastin)FDA Link 04/2014 - 07/2009
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2012 - 07/2009
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2011 - 09/2010
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 12/2023
1	Estrogen ReceptorsIBA 12/2023
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 12/2023
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 12/2023
1	Azacitidine (5 Azacytidine)FDA Link 12/2023
1	Decitabine FDA Link 12/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2022
1	Indomethacin (Indometacin)FDA LinkGeneric 12/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	2'-deoxy-4'-thiocytidineIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	methoxyamineIBA 11/2020
1	MethyltransferasesIBA 01/2020
1	nilotinib FDA Link 01/2020
1	talazoparibIBA 01/2020
1	TubulinIBA 01/2020
1	TetrahydrouridineIBA 01/2020
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	CateninsIBA 01/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	5-fluoro-2'-deoxycytidineIBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2020
1	pazopanib FDA Link 01/2020
1	VimentinIBA 01/2020
1	indimitecanIBA 12/2018
1	CamptothecinIBA 12/2018
1	Cisplatin (Platino)FDA LinkGeneric 03/2018
1	Formaldehyde (Formol)FDA Link 03/2018
1	ParaffinIBA 03/2018
1	ARQ 197IBA 01/2018
1	defactinibIBA 01/2018
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2018
1	EMD1214063IBA 01/2018
1	cabozantinibIBA 01/2018
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2018
1	GSK 1363089IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	tepotinibIBA 01/2018
1	Carboplatin (JM8)FDA LinkGeneric 02/2017
1	Poly (ADP-Ribose) Polymerase-1IBA 02/2017
1	Baculoviral IAP Repeat-Containing 3 ProteinIBA 02/2016
1	Caspase 3 (Caspase-3)IBA 02/2016

Therapy/Procedure

11	Therapeutics 12/2022 - 07/2009
2	Radiotherapy 01/2017 - 01/2015
2	Oral Administration 06/2015 - 03/2012
1	Aftercare (After-Treatment) 12/2018